Blue Jay Capital Management as of June 30, 2015
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 28 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CIGNA Corporation | 5.4 | $20M | 124k | 162.00 | |
| Aetna | 5.2 | $19M | 150k | 127.46 | |
| Humana (HUM) | 5.2 | $19M | 100k | 191.28 | |
| Cooper Companies | 4.8 | $18M | 101k | 177.97 | |
| Centene Corporation (CNC) | 4.6 | $17M | 211k | 80.40 | |
| Health Net | 4.4 | $16M | 256k | 64.12 | |
| Mylan Nv | 4.4 | $16M | 240k | 67.86 | |
| Shire | 4.3 | $16M | 66k | 241.49 | |
| Perrigo Company (PRGO) | 4.2 | $16M | 85k | 184.84 | |
| Receptos | 4.1 | $15M | 80k | 190.05 | |
| Impax Laboratories | 4.0 | $15M | 325k | 45.92 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $14M | 115k | 123.48 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $13M | 95k | 136.78 | |
| Alexion Pharmaceuticals | 3.4 | $13M | 70k | 180.77 | |
| ACADIA Pharmaceuticals (ACAD) | 3.4 | $13M | 300k | 41.88 | |
| Cepheid | 3.4 | $13M | 205k | 61.15 | |
| Alkermes (ALKS) | 3.2 | $12M | 188k | 64.34 | |
| Edwards Lifesciences (EW) | 3.1 | $12M | 82k | 142.43 | |
| Nektar Therapeutics (NKTR) | 3.1 | $12M | 925k | 12.51 | |
| Alere | 3.0 | $11M | 215k | 52.75 | |
| Teva Pharmaceutical Industries (TEVA) | 2.8 | $10M | 175k | 59.10 | |
| Sirona Dental Systems | 2.7 | $10M | 100k | 100.42 | |
| Thoratec Corporation | 2.6 | $9.6M | 215k | 44.57 | |
| Smith & Nephew (SNN) | 2.5 | $9.3M | 275k | 33.95 | |
| Wright Medical | 2.5 | $9.2M | 350k | 26.26 | |
| Qiagen | 2.4 | $9.0M | 364k | 24.79 | |
| DENTSPLY International | 2.1 | $7.7M | 150k | 51.55 | |
| NuVasive | 1.9 | $7.1M | 150k | 47.38 |
